Change search criteria ↓

Search results

200 projects found matching your search criteria:

  1. 1. MIST: Artificial intelligence-assisted design of experiments as a tool to streamline the development of siRNA-lipid nano…

    Principal investigator: dr hab. Paulina Krystyna Skupin-Mrugalska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: OPUS 29, Panel: NZ7

  2. 2. CTC-on-CAM: a platform for studying heterogeneity, epithelial-mesenchymal transition, and therapeutic sensitivity of cir…

    Principal investigator: prof. Marek Arkadiusz Murias

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: OPUS 29, Panel: NZ7

  3. 3. Three to tango - biomaterials with therapeutic and regenerative multifunctionality

    Principal investigator: dr Marzena Krystyna Fandzloch

    Instytut Niskich Temperatur i Badań Strukturalnych im. Włodzimierza Trzebiatowskiego PAN

    Call: SONATA BIS 13, Panel: ST11

  4. 4. Prioritizing diagnostics and therapeutics of human prion diseases through integrative omics

    Principal investigator: prof. Beata Katarzyna Sikorska

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: JPND Call 2023, Panel: NZ2

  5. 5. Modulation of immune cells activity in the tumor microenvironment by oligonucleotide therapeutics delivered by silk nano…

    Principal investigator: prof. Hanna Dams-Kozłowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: OPUS 19, Panel: NZ6

  6. 6. Therapeutic activation and signalling determinants of the autoregulatory MBNL1 expression in myotonic dystrophy.

    Principal investigator: dr Ewa Agnieszka Stępniak-Konieczna

    Uniwersytet Przyrodniczy w Poznaniu, Wydział Rolnictwa, Ogrodnictwa i Biotechnologii

    Call: OPUS 19, Panel: NZ5

  7. 7. Improving the healing potential of therapeutic proteins by planned, specific modifiactions on the example of bacteriolyt…

    Principal investigator: Marek Harhala

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: PRELUDIUM 18, Panel: NZ6

  8. 8. Experimental investigations and computer modelling of heat transfer processes in therapeutic hypothermia of a newborn's …

    Principal investigator: prof. Andrzej Józef Nowak

    Politechnika Śląska, Wydział Inżynierii Środowiska i Energetyki

    Call: OPUS 15, Panel: ST8

  9. 9. Peroxiredoxins as potential therapeutic targets in glioblastoma.

    Principal investigator: dr hab. Monika Paulina Szeliga

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 13, Panel: NZ7

  10. 10. Interactions between biologically active phytocompounds present in the fodder and selected therapeuticals used in the th…

    Principal investigator: dr hab. Marta Mendel

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

    Call: SONATA 3, Panel: NZ9

  11. 11. In vitro models for therapeutic proteins secretion in avian oviduct epithelial cells.

    Principal investigator: dr Katarzyna Stadnicka

    Uniwersytet Technologiczno-Przyrodniczy im. Jana i Jędrzeja Śniadeckich w Bydgoszczy, Wydział Hodowli i Biologii Zwierząt

    Call: PRELUDIUM 2, Panel: NZ9

  12. 12. Development of Molecular and Supramolecular Tools to Exploit Human Copper(I) Homeostasis for Cancer Therapeutics

    Principal investigator: dr JEENA Manayath Thekkeyil

    Instytut Chemii Fizycznej Polskiej Akademii Nauk

    Call: SONATA BIS 15, Panel: ST5

  13. 13. Destabilization of neuronal morphology in chronic inflammation: molecular mechanisms and identification of potential the…

    Principal investigator: prof. Jacek Ryszard Jaworski

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej

    Call: OPUS 29, Panel: NZ5

  14. 14. Astrocytic Mitochondria in PACS2 Syndrome: Pathogenesis and Therapeutic Intervention

    Principal investigator: Arkadiusz Franciszek Żbikowski

    Uniwersytet Medyczny w Białymstoku

    Call: PRELUDIUM 24, Panel: NZ5

  15. 15. TP53 mutations drive alternative FGFR1 splicing - the study of consequences for cancer progression and therapeutic oppor…

    Principal investigator: Weronika Wojtyś

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: PRELUDIUM 24, Panel: NZ4

  16. 16. Investigation of the therapeutic potential of natural flavour and fragrance materials in inflammatory oral diseases indu…

    Principal investigator: Zuzanna Maria Bacińska

    Politechnika Wrocławska

    Call: PRELUDIUM 24, Panel: NZ1

  17. 17. The JAK/STAT pathway as a molecular contributor to the development of endometriosis: therapeutic potential of JAK inhibi…

    Principal investigator: Aleksander Radosław Rycerz

    Uniwersytet Medyczny w Łodzi

    Call: PRELUDIUM 24, Panel: NZ7

  18. 18. Cholesin and its receptor as novel therapeutic and diagnostic targets in metabolic disorders

    Principal investigator: prof. Wojciech Fendler

    Uniwersytet Medyczny w Łodzi

    Call: OPUS 29, Panel: NZ7

  19. 19. Therapeutic evaluation of anti-fibrotic agents for thyroid eye disease (TED) in a preclinical mouse model

    Principal investigator: Paweł Franciszek Tyrna

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

    Call: PRELUDIUM 24, Panel: NZ6

  20. 20. Therapeutic potential of an FGF21 analogue in HFpEF: targeting cardiac, skeletal muscle, and cognitive function to impro…

    Principal investigator: Maria Katarzyna Głowienka-Stodolak

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

    Call: PRELUDIUM 24, Panel: NZ4

  21. 21. Targeted Degradation of the MLL Complex in Leukemia: A PROTAC-Based Therapeutic Strategy

    Principal investigator: dr Natalia Anna Skrzypczak

    Fundacja Uniwersytetu im. Adama Mickiewicza

    Call: SONATINA 9, Panel: ST5

  22. 22. Antibacterial molecules based on bacteriophage proteins and constant antibody fragments with therapeutic potential for t…

    Principal investigator: dr Karolina Aleksandra Filik-Matyjaszczyk

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: SONATA 20, Panel: NZ7

  23. 23. Modulating Neuroplasticity with Psilocybin: Assesment Therapeutic Potential in Treating Fentanyl use disorder

    Principal investigator: dr hab. Ewa Taracha

    Instytut Psychiatrii i Neurologii

    Call: OPUS 28, Panel: NZ7

  24. 24. Identifying early biomarkers and molecular targets for therapeutic intervention in right ventricular dysfunction

    Principal investigator: prof. Przemysław Błyszczuk

    Uniwersytet Jagielloński

    Call: OPUS 28, Panel: NZ5

  25. 25. Porous bioglass-alginate composite granules as the antibiotic delivery system with therapeutic and regenerative potentia…

    Principal investigator: dr Adrian Szewczyk

    Gdański Uniwersytet Medyczny

    Call: SONATA 20, Panel: NZ7

  26. 26. A triple agonist of glucagon, GLP-1, and GIP receptors as a novel therapeutic option for the treatment of heart failure …

    Principal investigator: dr Marta Katarzyna Oknińska

    CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

    Call: SONATA 20, Panel: NZ5

  27. 27. Selective autophagy-mediated protein degradation as a potential therapeutic strategy for the treatment of inflammatory c…

    Principal investigator: dr hab. Monika Emilia Marcinkowska

    Uniwersytet Jagielloński

    Call: OPUS 28, Panel: NZ7

  28. 28. A comprehensive structural and functional analysis of toxic RNA-protein interactions for better understanding and therap…

    Principal investigator: dr hab. Agnieszka Ludmiła Kiliszek

    Instytut Chemii Bioorganicznej PAN

    Call: OPUS 28 (LAP), Panel: NZ5

  29. 29. The H3K27M oncohistone-centred molecular mechanisms as therapeutic targets in pediatric malignant diffuse midline glioma…

    Principal investigator: dr Katarzyna Leszczyńska

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: SONATA BIS 14, Panel: NZ3

  30. 30. Improving the therapeutic potential of cytostatics through the use of abiotic metallacarboranes.

    Principal investigator: Michalina Gos

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: PRELUDIUM 23, Panel: NZ7

  31. 31. Development of novel potential therapeutics in inflammatory bowel diseases based on nanoformulations employing senomodul…

    Principal investigator: prof. Jakub Jerzy Fichna

    Uniwersytet Medyczny w Łodzi

    Call: OPUS 27, Panel: NZ7

  32. 32. CD147 as a novel multifunctional modulator of podocyte metabolism and exosome biogenesis: Identification of new molecula…

    Principal investigator: dr hab. Agnieszka Piwkowska

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

    Call: OPUS 27, Panel: NZ4

  33. 33. Innovative diagnostic and therapeutic strategies targeting inflammation in periodontitis.

    Principal investigator: dr Maja Sochalska

    Uniwersytet Jagielloński

    Call: OPUS 27, Panel: NZ5

  34. 34. Is there an escape from antibioticresistant ESKAPE pathogens present in wastewater - the importance of last-chance antib…

    Principal investigator: dr Katarzyna Natalia Grudlewska-Buda

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy

    Call: SONATA 19, Panel: NZ9

  35. 35. Modulation of protein interaction networks as a new therapeutic target in the treatment of hereditary retinal dystrophie…

    Principal investigator: dr Xiaonan Liu

    Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Medycznych w Katowicach

    Call: SONATA 19, Panel: NZ5

  36. 36. Evaluation of the therapeutic potential of synthetic miRNA-223-3p analog in a rat model of severe asthma

    Principal investigator: dr Wojciech Jerzy Langwiński

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: SONATA 19, Panel: NZ4

  37. 37. Actin cytoskeleton disorders as a pro-survival signaling activator and a therapeutic biomarker in Diffuse Large B-cell L…

    Principal investigator: dr Patryk Górniak

    Instytut Hematologii i Transfuzjologii

    Call: SONATA BIS 13, Panel: NZ5

  38. 38. Targeting IGH enhancer RNAs as a therapeutic approach in B-cell lymphoma

    Principal investigator: dr hab. Agnieszka Dzikiewicz-Krawczyk

    Instytut Genetyki Człowieka PAN

    Call: SONATA BIS 13, Panel: NZ1

  39. 39. Exploring the Therapeutic Effects of Human Adipose Tissue Mesenchymal Stem Cell (HATMSC) line Secretome on Chronic Skin …

    Principal investigator: dr Honorata Kraśkiewicz

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: SONATA BIS 13, Panel: NZ3

  40. 40. The inhibition of NMDAR and TRPM4 coupling - a hope for novel therapeutic target for the treatment of the ischemic brain…

    Principal investigator: dr Bartosz Sebastian Pomierny

    Uniwersytet Jagielloński, Collegium Medicum

    Call: SONATA BIS 13, Panel: NZ7

  41. 41. Extensive analysis of the immunological profile of pediatric patients with acute lymphoblastic leukemia in order to iden…

    Principal investigator: Anna Krętowska-Grunwald

    Uniwersytet Medyczny w Białymstoku

    Call: PRELUDIUM 22, Panel: NZ5

  42. 42. Cuproptosis, a novel pathway of regulated cell death as a therapeutic target in treatment-naïve and targeted therapy-res…

    Principal investigator: dr hab. Mariusz Łukasz Hartman

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

    Call: OPUS 25, Panel: NZ5

  43. 43. Bigels with controlled release of hydrophilic and hydrophobic therapeutic compounds as potential dressings in the treatm…

    Principal investigator: dr hab. Monika Gosecka

    Centrum Badań Molekularnych i Makromolekularnych PAN

    Call: OPUS 25, Panel: ST11

  44. 44. Selective PPARγ modulation by amorfrutin B as a novel therapeutic approach to chemotherapy-induced damage to mammalian b…

    Principal investigator: Bernadeta Angelika Pietrzak-Wawrzyńska

    Instytut Farmakologii PAN

    Call: PRELUDIUM 22, Panel: NZ7

  45. 45. Therapeutic self-understanding

    Principal investigator: dr Jędrzej Piotr Grodniewicz

    Uniwersytet Jagielloński, Centrum Kopernika Badań Interdyscyplinarnych Uniwersytetu Jagiellońskiego

    Call: SONATA 18, Panel: HS1

  46. 46. Specific immune signatures of T cells as biomarkers of the post-COVID Syndrome and predictors of long-term health dysfun…

    Principal investigator: dr hab. Katarzyna Piwocka

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: PRELUDIUM BIS 4, Panel: NZ6

  47. 47. Molecular insights into hypoxic tumors – for development of targeted cancer therapeutics

    Principal investigator: dr Marco Deiana

    Politechnika Wrocławska

    Call: POLONEZ BIS 3, Panel: NZ5

  48. 48. Computational deciphering of pro-ferroptotic cell death protein machinery as a fundamental step in the search for therap…

    Principal investigator: dr hab. Karolina Anna Mikulska-Rumińska

    Uniwersytet Mikołaja Kopernika, Wydział Fizyki, Astronomii i Informatyki Stosowanej

    Call: SONATA BIS 12, Panel: ST4

  49. 49. Studies on the post-receptor mechanisms of TSPO in search of a novel therapeutic target of metabolic syndrome

    Principal investigator: dr Łukasz Kurach

    Uniwersytet Medyczny w Lublinie

    Call: PRELUDIUM 21, Panel: NZ7

  50. 50. The role of simultaneous and individual modulation of μ-opioid, sigma-1 and histamine H3 receptors as a new therapeutic …

    Principal investigator: dr Katarzyna Anna Szczepańska

    Instytut Farmakologii PAN

    Call: OPUS 23, Panel: NZ7

Graphic design and implementation: Jakub Piotrowski